Literature DB >> 27816449

A missense methionine mutation augments catalytic activity but reduces thermal stability in two protein tyrosine phosphatases.

Anthony C Bishop1.   

Abstract

Recent data sets that catalog the missense mutations in thousands of human genomes have revealed a vast and largely unexplored world of non-canonical protein sequences that are expressed in humans. The functional consequences of most human missense mutations, however, are unknown, and the accuracy with which their effects can be predicted by computational algorithms remains unclear. Among humans of European descent, the most common missense mutation in the catalytic domain of SH2-containing protein tyrosine phosphatase 1 (SHP-1) converts the enzyme's canonical valine 451 to methionine (V451M). The V451M mutation lies in a conserved motif adjacent to the protein tyrosine phosphatase (PTP) consensus sequence and is predicted to compromise catalytic function. In this study it is shown that, counter to prediction, V451M SHP-1 possesses increased catalytic activity as compared to the wild-type enzyme. Additionally, a PTP-wide search of missense-mutation data revealed a variant of one other PTP, Fas-associated PTP (FAP-1), that contains a methionine mutation at the position corresponding to 451 of SHP-1 (T2406M FAP-1). It is shown here that the T2406M mutation increases FAP-1's PTP activity, to a degree that is comparable to the activation deriving from the V451M mutation in SHP-1. Although the two non-canonical methionine residues confer increased activity at moderate temperatures, both V451M SHP-1 and T2406M FAP-1 are less thermally stable than their canonical counterparts, as demonstrated by the mutants' strongly reduced activities at high temperatures. These results highlight the challenges in predicting the functional consequences of missense mutations, which can differ under varying conditions, and suggest that, with regard to position 451/2406, canonical PTP domains have "chosen" stability over optimized activity during the course of evolution.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FAP-1; Missense mutations; Protein tyrosine phosphatases; SHP-1

Mesh:

Substances:

Year:  2016        PMID: 27816449      PMCID: PMC5118098          DOI: 10.1016/j.bbrc.2016.11.001

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

Review 1.  Structural and evolutionary relationships among protein tyrosine phosphatase domains.

Authors:  J N Andersen; O H Mortensen; G H Peters; P G Drake; L F Iversen; O H Olsen; P G Jansen; H S Andersen; N K Tonks; N P Møller
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

2.  Crystal structure of human protein-tyrosine phosphatase SHP-1.

Authors:  Jian Yang; Lijun Liu; Dandan He; Xi Song; Xiaoshan Liang; Zhizhuang Joe Zhao; G Wayne Zhou
Journal:  J Biol Chem       Date:  2002-12-13       Impact factor: 5.157

3.  Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia.

Authors:  Marco Tartaglia; Charlotte M Niemeyer; Alessandra Fragale; Xiaoling Song; Jochen Buechner; Andreas Jung; Karel Hählen; Henrik Hasle; Jonathan D Licht; Bruce D Gelb
Journal:  Nat Genet       Date:  2003-06       Impact factor: 38.330

Review 4.  Structure, function, and pathogenesis of SHP2 in developmental disorders and tumorigenesis.

Authors:  Wen-Qing Huang; Qing Lin; Xuan Zhuang; Liang-Liang Cai; Run-Sheng Ruan; Zhong-Xian Lu; Chi-Meng Tzeng
Journal:  Curr Cancer Drug Targets       Date:  2014       Impact factor: 3.428

Review 5.  The function of the protein tyrosine phosphatase SHP-1 in cancer.

Authors:  Chengyu Wu; Mingzhong Sun; Lijun Liu; G Wayne Zhou
Journal:  Gene       Date:  2003-03-13       Impact factor: 3.688

Review 6.  PTPL1: a large phosphatase with a split personality.

Authors:  Ogan D Abaan; Jeffrey A Toretsky
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

7.  Targeting a cryptic allosteric site for selective inhibition of the oncogenic protein tyrosine phosphatase Shp2.

Authors:  Cynthia M Chio; Christopher S Lim; Anthony C Bishop
Journal:  Biochemistry       Date:  2015-01-02       Impact factor: 3.162

8.  Comprehensive Analysis of Disease-Related Genes in Chronic Lymphocytic Leukemia by Multiplex PCR-Based Next Generation Sequencing.

Authors:  Claudia Vollbrecht; Fabian Dominik Mairinger; Ulrike Koitzsch; Martin Peifer; Katharina Koenig; Lukas Carl Heukamp; Giuliano Crispatzu; Laura Wilden; Karl-Anton Kreuzer; Michael Hallek; Margarete Odenthal; Carmen Diana Herling; Reinhard Buettner
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

9.  An integrated map of genetic variation from 1,092 human genomes.

Authors:  Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

Review 10.  Optimization to low temperature activity in psychrophilic enzymes.

Authors:  Caroline Struvay; Georges Feller
Journal:  Int J Mol Sci       Date:  2012-09-17       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.